Impact of Short-Term Administration of Oral Minocycline, a Repurposed Anti-Neuroinflammatory Agent, on MR and Neuropsychological Biomarkers of MCI and AD

Keywords

abbreviated accrual acknowledgments activity administration agents animal animals annum anti anticipate appropriate approved arch assessment background batteries battery become benefit bipolar blind brain brewer broadly cerebral clearance clinical combined community complete confirmation controlled cornerstone correlation cost currently daily defined describes design deteriorated development diagnosis disappointing disease disorder distinguished drug drugs eight elderly encountered enter examinations exams expressed family foundation frontiers function generation hepatic hospital hour human hyper improved improvement index initial knowledge label lacking linear living measure measures memorial miller modest monitored month monthly months negative newer nick notably novel open oral outcome pair patients pharmacy pilot placebo positive posterior power press prevention progression properties protective proven psychiatry published quantifiable rather recent reduced remained removal renal repeatable respectively response reversal sage schizophrenia serial series short shortly significance significantly sporadic statistical statistically status stroke studies subject subjects successful supported term tetracycline throughout tolerated toxicity treatment trial trials twice underwent untreated volume weeks